MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202441047693 A) filed by Sciinv Biosciences Pvt. Ltd., Hyderabd, Telangana, on Dec. 21, 2024, for 'generative ai based antimicrobial resistance drug discovery platform.'
Inventor(s) include Uday Saxena; Pallu Reddanna; Ranga Reddy Burri; Bulagonda Eswarappa Pradeep; Palakodeti Ratnakar; Ravi Kumar Meduri; and Ratna Sushmita Mandavalli.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a field of using generative artificial intelligence for drug repurposing. The current invention uses artificial intelligence enabled platform (100) for drug repurposing by generating an ideal candidate drug molecule. The present invention discloses the platform (100) comprising an information processing apparatus (104), a user device (102) and a communication network (106). Further, the present invention discloses the artificial intelligence-based method (400) to identify a candidate drug molecule as antimicrobials, or developing new antimicrobial drugs. The method includes a receiving step (402), a display step (404), a fetching step (406), a embedding step (408), a selecting step (410), a simulating step (412), a predicting step (414), a generating step (416), a fetching and displaying step (418), a screening and identifying step (420), and a validating step (422) to greatly enhance percentage of candidate drug molecule identified for combating AMR."
Disclaimer: Curated by HT Syndication.
